{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:40:36Z","timestamp":1789540836260,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,24]],"date-time":"2014-05-24T00:00:00Z","timestamp":1400889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00417-014-2660-0","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T23:20:36Z","timestamp":1400800836000},"page":"1319-1327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Upregulation of hypoxia-inducible factors and autophagy in von Hippel\u2013Lindau-associated retinal hemangioblastoma"],"prefix":"10.1007","volume":"252","author":[{"given":"Yujuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mones S.","family":"Abu-Asab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chao","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,24]]},"reference":[{"key":"2660_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","volume":"28","author":"ER Maher","year":"1991","unstructured":"Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA, Morton N (1991) Von Hippel\u2013Lindau disease: a genetic study. J Med Genet 28:443\u2013447","journal-title":"J Med Genet"},{"key":"2660_CR2","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) Von Hippel\u2013Lindau disease. Lancet 361:2059\u20132067","journal-title":"Lancet"},{"key":"2660_CR3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","volume":"332","author":"BR Seizinger","year":"1988","unstructured":"Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JW, Collins D, Majoor-Krakauer D et al (1988) Von Hippel\u2013Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268\u2013269","journal-title":"Nature"},{"key":"2660_CR4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.117.5.625","volume":"117","author":"CC Chan","year":"1999","unstructured":"Chan CC, Vortmeyer AO, Chew EY, Green WR, Matteson DM, Shen DF, Linehan WM, Lubensky IA, Zhuang Z (1999) VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol 117:625\u2013630","journal-title":"Arch Ophthalmol"},{"key":"2660_CR5","first-page":"75","volume":"102","author":"CC Chan","year":"2004","unstructured":"Chan CC, Lee YS, Zhuang Z, Hackett J, Chew EY (2004) Von Hippel\u2013Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma. Trans Am Ophthalmol Soc 102:75\u201379, discussion 79\u201381","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2660_CR6","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"CJ Hu","year":"2003","unstructured":"Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23:9361\u20139374","journal-title":"Mol Cell Biol"},{"key":"2660_CR7","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/0008-5472.CAN-04-4130","volume":"65","author":"V Wang","year":"2005","unstructured":"Wang V, Davis DA, Haque M, Huang LE, Yarchoan R (2005) Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res 65:3299\u20133306","journal-title":"Cancer Res"},{"key":"2660_CR8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4161\/cc.6.8.4133","volume":"6","author":"T Lofstedt","year":"2007","unstructured":"Lofstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, Pahlman S (2007) Hypoxia inducible factor-2alpha in cancer. Cell Cycle 6:919\u2013926","journal-title":"Cell Cycle"},{"key":"2660_CR9","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/onc.2008.160","volume":"27","author":"EB Rankin","year":"2008","unstructured":"Rankin EB, Rha J, Unger TL, Wu CH, Shutt HP, Johnson RS, Simon MC, Keith B, Haase VH (2008) Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27:5354\u20135358","journal-title":"Oncogene"},{"key":"2660_CR10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ijc.24032","volume":"124","author":"T Imamura","year":"2009","unstructured":"Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, Mino-Kenduson M, Lynch MP, Rueda BR, Benita Y, Xavier RJ, Chung DC (2009) HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer 124:763\u2013771","journal-title":"Int J Cancer"},{"key":"2660_CR11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.117.3.371","volume":"117","author":"AR Webster","year":"1999","unstructured":"Webster AR, Maher ER, Moore AT (1999) Clinical characteristics of ocular angiomatosis in von Hippel\u2013Lindau disease and correlation with germline mutation. Arch Ophthalmol 117:371\u2013378","journal-title":"Arch Ophthalmol"},{"key":"2660_CR12","first-page":"3067","volume":"43","author":"H Dollfus","year":"2002","unstructured":"Dollfus H, Massin P, Taupin P, Nemeth C, Amara S, Giraud S, Beroud C, Dureau P, Gaudric A, Landais P, Richard S (2002) Retinal hemangioblastoma in von Hippel\u2013Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci 43:3067\u20133074","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2660_CR13","first-page":"OP446","volume":"83","author":"WH Annesley Jr","year":"1977","unstructured":"Annesley WH Jr, Leonard BC, Shields JA, Tasman WS (1977) Fifteen year review of treated cases of retinal angiomatosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 83:OP446\u2013OP453","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"2660_CR14","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0161-6420(02)01177-6","volume":"109","author":"AD Singh","year":"2002","unstructured":"Singh AD, Nouri M, Shields CL, Shields JA, Perez N (2002) Treatment of retinal capillary hemangioma. Ophthalmology 109:1799\u20131806","journal-title":"Ophthalmology"},{"key":"2660_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/ICU.0b013e3282fb7c04","volume":"19","author":"WT Wong","year":"2008","unstructured":"Wong WT, Chew EY (2008) Ocular von Hippel\u2013Lindau disease: clinical update and emerging treatments. Curr Opin Ophthalmol 19:213\u2013217","journal-title":"Curr Opin Ophthalmol"},{"key":"2660_CR16","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0161-6420(98)99036-4","volume":"105","author":"DF Shen","year":"1998","unstructured":"Shen DF, Zhuang Z, LeHoang P, Boni R, Zheng S, Nussenblatt RB, Chan CC (1998) Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 105:1664\u20131669","journal-title":"Ophthalmology"},{"key":"2660_CR17","first-page":"620","volume":"146","author":"Z Zhuang","year":"1995","unstructured":"Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, Lubensky IA (1995) A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size. Am J Pathol 146:620\u2013625","journal-title":"Am J Pathol"},{"key":"2660_CR18","first-page":"275","volume":"101","author":"CC Chan","year":"2003","unstructured":"Chan CC (2003) Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc 101:275\u2013292","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2660_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ophtha.2006.05.068","volume":"114","author":"X Liang","year":"2007","unstructured":"Liang X, Shen D, Huang Y, Yin C, Bojanowski CM, Zhuang Z, Chan CC (2007) Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel\u2013Lindau disease. Ophthalmology 114:147\u2013156","journal-title":"Ophthalmology"},{"key":"2660_CR20","first-page":"4337","volume":"29","author":"MR Morris","year":"2009","unstructured":"Morris MR, Hughes DJ, Tian YM, Ricketts CJ, Lau KW, Gentle D, Shuib S, Serrano-Fernandez P, Lubinski J, Wiesener MS, Pugh CW, Latif F, Ratcliffe PJ, Maher ER (2009) Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma. Anticancer Res 29:4337\u20134343","journal-title":"Anticancer Res"},{"key":"2660_CR21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","volume":"8","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin WG Jr (2008) The von Hippel\u2013Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 8:865\u2013873","journal-title":"Nat Rev Cancer"},{"key":"2660_CR22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","volume":"15","author":"GL Semenza","year":"1999","unstructured":"Semenza GL (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551\u2013578","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2660_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(02)00044-2","volume":"1","author":"JK Maranchie","year":"2002","unstructured":"Maranchie JK, Vasselli JR, Riss J, Bonifacino JS, Linehan WM, Klausner RD (2002) The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 1:247\u2013255","journal-title":"Cancer Cell"},{"key":"2660_CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","volume":"1","author":"K Kondo","year":"2002","unstructured":"Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG Jr (2002) Inhibition of HIF is necessary for tumor suppression by the von Hippel\u2013Lindau protein. Cancer Cell 1:237\u2013246","journal-title":"Cancer Cell"},{"key":"2660_CR25","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1073\/pnas.140087397","volume":"97","author":"J Peng","year":"2000","unstructured":"Peng J, Zhang L, Drysdale L, Fong GH (2000) The transcription factor EPAS-1\/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci U S A 97:8386\u20138391","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2660_CR26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccr.2006.08.026","volume":"10","author":"L Holmquist-Mengelbier","year":"2006","unstructured":"Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A, Gradin K, Poellinger L, Pahlman S (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10:413\u2013423","journal-title":"Cancer Cell"},{"key":"2660_CR27","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","volume":"367","author":"Z Zhuang","year":"2012","unstructured":"Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K (2012) Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med 367:922\u2013930","journal-title":"N Engl J Med"},{"key":"2660_CR28","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2012-10-460972","volume":"121","author":"C Yang","year":"2013","unstructured":"Yang C, Sun MG, Matro J, Huynh TT, Rahimpour S, Prchal JT, Lechan R, Lonser R, Pacak K, Zhuang Z (2013) Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas. Blood 121:2563\u20132566","journal-title":"Blood"},{"key":"2660_CR29","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.ophtha.2013.07.046","volume":"120","author":"AJ Lotery","year":"2013","unstructured":"Lotery AJ, Gibson J, Cree AJ, Downes SM, Harding SP, Rogers CA, Reeves BC, Ennis S, Chakravarthy U (2013) Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study. Ophthalmology 120:2637\u20132643","journal-title":"Ophthalmology"},{"key":"2660_CR30","first-page":"341","volume":"30","author":"SK Park","year":"2007","unstructured":"Park SK, Haase VH, Johnson RS (2007) Von Hippel\u2013Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase. Int J Oncol 30:341\u2013348","journal-title":"Int J Oncol"},{"key":"2660_CR31","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/MCB.00200-09","volume":"29","author":"EB Rankin","year":"2009","unstructured":"Rankin EB, Rha J, Selak MA, Unger TL, Keith B, Liu Q, Haase VH (2009) Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 29:4527\u20134538","journal-title":"Mol Cell Biol"},{"key":"2660_CR32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc1692","volume":"5","author":"Y Kondo","year":"2005","unstructured":"Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:726\u2013734","journal-title":"Nat Rev Cancer"},{"key":"2660_CR33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ccr.2008.06.004","volume":"14","author":"S Turcotte","year":"2008","unstructured":"Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ (2008) A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 14:90\u2013102","journal-title":"Cancer Cell"},{"key":"2660_CR34","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1073\/pnas.0907550106","volume":"106","author":"HB Schonthaler","year":"2009","unstructured":"Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF (2009) Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci U S A 106:21264\u201321269","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2660_CR35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-009-1101-y","volume":"247","author":"M Saravia","year":"2009","unstructured":"Saravia M, Zapata G, Ferraiolo P, Racca L, Berra A (2009) Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol 247:1409\u20131416","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2660_CR36","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1167\/iovs.11-9119","volume":"53","author":"S Nakao","year":"2012","unstructured":"Nakao S, Arima M, Ishikawa K, Kohno R, Kawahara S, Miyazaki M, Yoshida S, Enaida H, Hafezi-Moghadam A, Kono T, Ishibashi T (2012) Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Invest Ophthalmol Vis Sci 53:4323\u20134328","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2660_CR37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpedsurg.2011.11.028","volume":"47","author":"A Chernoguz","year":"2012","unstructured":"Chernoguz A, Crawford K, Vandersall A, Rao M, Willson T, Denson LA, Frischer JS (2012) Pretreatment with anti-VEGF therapy may exacerbate inflammation in experimental acute colitis. J Pediatr Surg 47:347\u2013354","journal-title":"J Pediatr Surg"},{"key":"2660_CR38","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/neuonc\/nos158","volume":"14","author":"Y Piao","year":"2012","unstructured":"Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, de Groot JF (2012) Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol 14:1379\u20131392","journal-title":"Neuro Oncol"},{"key":"2660_CR39","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1189\/jlb.0905495","volume":"80","author":"AE Dirkx","year":"2006","unstructured":"Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW (2006) Monocyte\/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 80:1183\u20131196","journal-title":"J Leukoc Biol"},{"key":"2660_CR40","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","volume":"104","author":"C Murdoch","year":"2004","unstructured":"Murdoch C, Giannoudis A, Lewis CE (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104:2224\u20132234","journal-title":"Blood"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-014-2660-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2660-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T15:27:11Z","timestamp":1565450831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-014-2660-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,24]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1007\/s00417-014-2660-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,24]]}}}